Cagrilintide 2.4 mg alone achieved approximately 10.8% weight loss over the same period, while semaglutide 2.4 mg alone achieved about 16%
The four-pathway approach activates mechanisms that single or dual agonists cannot reach, potentially overcoming resistance that develops with prolonged use of less comprehensive compounds
Mast cells, distributed throughout the gut, lung, and brain, become primed and start releasing histamine, tryptase, and inflammatory mediators in response to ordinary stimuli
7.1 Large-scale randomized controlled trials Current clinical trials are predominantly constrained by insufficient sample sizes, single-center designs, and short intervention durations
That is the core difference